Lupin ropes in Jon Stelzmiller to head US specialty business
Homegrown pharma major Lupin on Wednesday announced appointment of Jon Stelzmiller as the President of its US specialty business. Stelzmiller, who was most recently Senior Vice-President and General Manager - Women's Healthcare at Bayer, will be replacing Nicholas Hart, Lupin said in a statement.
"Jon's extensive experience in the pharmaceutical industry, particularly in women's health segment in the US, will be a great asset for Lupin as we build our specialty business," Lupin CEO Vinita Gupta said.
He brings over 30 years of experience in specialty segment and has a proven track record of building high performing teams and launching 18 major brands across 14 different therapeutic areas, including women's health, oncology and anti-infectives, the statement said.